Rue Edouard Belin 12
Mont-Saint-Guibert 1435
Belgium
32 10 22 23 55
https://www.nyxoah.com
Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo: 146
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Robert Taub MBA | Co-Founder & Chairman | 127,63k | N/A | 1947 |
Mr. Olivier Taelman | CEO & Executive Director | 807,1k | N/A | 1972 |
Mr. Loic Moreau | Chief Financial Officer | 468,69k | N/A | 1981 |
Mr. Bruno Onkelinx | Chief Technology Officer | N/A | N/A | N/A |
Mikaela Kirkwood | Corporate Communication & Investor Relations Manager | N/A | N/A | N/A |
Ms. An Moonen | General Counsel | N/A | N/A | N/A |
Ms. Inge Vanwittenbergh | Global Human Resource Director | N/A | N/A | N/A |
Mr. David M. DeMartino | Chief Strategy Officer | N/A | N/A | N/A |
Mr. Remi Renard | Chief of Staff | N/A | N/A | N/A |
Mr. Jeyakumar Subbaroyan | Chief Clinical Officer | N/A | N/A | N/A |
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
El ISS Governance QualityScore de Nyxoah S.A., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.